SepticemiaNCT07148440
Acid Base Disorders in ICU in Minia University Hospital
An observational study of Septicemia, run by Minia University.
Trial summary
Data extracted from records of patients in the ICU regarding type and frequency of acid base disturbance that led to their admission to the ICU and correlation with 28-day mortality. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Septicemia
- How many people
- 900 participants
- Where
- No sites listed yet
- Study dates
- 23 Aug 2025to 31 Aug 2025
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: all icu patients with acid base abnormalities
Who may be able to join
- ICU admission with documented acid base disturbance
Who cannot join
- incomplete records
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Frequency and Types of Acid-Base Disorders in Intensive Care Unit Patients
Data extracted from records of patients in the ICU regarding type and frequency of acid base disturbance that led to their admission to the ICU and correlation with 28-day mortality.
- Conditions
- Septicemia
- Medical subject headings
- Sepsis
What is being measured
The primary outcome is the main question the study is designed to answer.
Types of acid- base disorders in ICU patients
Measured: from January 2021 to December 2024
Secondary outcomes (1)
28 day mortality
Measured: from January 2021 to December 2024
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Aug 2025
- Study start23 Aug 2025 (estimated)
- Primary completion31 Aug 2025 (estimated)
- Study completion31 Aug 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for SepticemiaStudies of the same condition, open and under way.
- More trials run by Minia UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 900 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Minia University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Sohair Adeeb, Minia University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07148440
- Sponsor's protocol ID
- Acid base disorders in ICU
- Status last verified
- Aug 2025
- First submitted
- 23 Aug 2025
- Last updated
- 29 Aug 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Achanti A, Szerlip HM. Acid-Base Disorders in the Critically Ill Patient. Clin J Am Soc Nephrol. 2023 Jan 1;18(1):102-112. doi: 10.2215/CJN.04500422. Epub 2022 Aug 23.
PubMed 35998977
Study at a glance
From the registry record, last updated by the sponsor on 29 Aug 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Frequency and Types of Acid-Base Disorders in Intensive Care Unit Patients
- ClinicalTrials.gov ID
- NCT07148440
- Acronym / sponsor ID
- Acid base disorders in ICU
- Conditions
- Septicemia
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 900 participants (estimated)
- Lead sponsor
- Minia UniversityUniversity, hospital or other
- Study start
- 23 Aug 2025 (estimated)
- Primary completion
- 31 Aug 2025 (estimated)
- Study completion
- 31 Aug 2025 (estimated)
- First posted
- 29 Aug 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Data extracted from records of patients in the ICU regarding type and frequency of acid base disturbance that led to their admission to the ICU and correlation with 28-day mortality.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- all icu patients with acid base abnormalities
Key inclusion criteria (1 listed)
- ICU admission with documented acid base disturbance
Key exclusion criteria (1 listed)
- incomplete records
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Types of acid- base disorders in ICU patients
Time frame: from January 2021 to December 2024
1 secondary outcome
28 day mortality
Time frame: from January 2021 to December 2024
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Aug 2025.
- Background: PubMed 35998977Achanti A, Szerlip HM. Acid-Base Disorders in the Critically Ill Patient. Clin J Am Soc Nephrol. 2023 Jan 1;18(1):102-112. doi: 10.2215/CJN.04500422. Epub 2022 Aug 23.
- Individual participant dataSharing planned: No
Related trials for Septicemia
Not yet recruitingPhase 2/3
A Pivotal Safety and Immunogenicity GBS-NN/NN2 Vaccine Maternal Immunisation Trial
Streptococcus Agalactiae Infection, Neonatal Sepsis
Active, not recruiting
CT for Personalized Mechanical Ventilation
Ventilator-Induced Lung Injury, Sepsis Syndrome
RecruitingPhase 4
A Study to Compare the Efficacy and Safety of Extended and Intermittent Infusion of Beta-lactams in Critically Ill Paediatric Patients
Infection, Sepsis
Not yet recruiting
Double Plasma Separation and Adsorption in Acute-on-Chronic Liver Failure (DPMAS-ACLF Trial)
Acute-on-Chronic Liver Failure (ACLF)
Active, not recruitingPhase 4
Thymosin Alpha 1 and IgM Levels in Sepsis
Sepsis, Septic Shock
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Questions about this trial
What is this clinical trial studying?
An observational study of Septicemia, run by Minia University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 29 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact sohair A Megalla, assistant professor (+201200036447, Sohair.Adeeb@minia.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Types of acid- base disorders in ICU patients (time frame: from January 2021 to December 2024). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07148440, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Aug 2025.